Gutierrez Euceda Belyin, Ferreri Stefanie P, Armistead Lori T
UNC Eshelman School of Pharmacy, 301 Pharmacy Lane, Chapel Hill, NC 27599-7475, United States.
Explor Res Clin Soc Pharm. 2023 Apr 21;10:100267. doi: 10.1016/j.rcsop.2023.100267. eCollection 2023 Jun.
Various clinical pharmacy services exist to improve the health outcomes of patients. However, there are numerous barriers to their implementation and execution, especially in outpatient settings. As pharmacists design and implement clinical pharmacy services in outpatient settings, they often do not consider the needs of providers until after service development.
The purpose of this study was to assess primary care providers' (PCPs') perceptions of clinical pharmacy services and their clinical pharmacy support needs.
A web-based survey was distributed via email to PCPs across North Carolina (NC). Survey dissemination was completed in two phases. Data analysis consisted of mixed methods - quantitative and qualitative. Descriptive statistics were used to analyze demographic differences within each phase as well as the ranking of medication classes/disease states by providers. Qualitative data analysis through inductive coding was done to assess provider perceptions of clinical pharmacy services.
The response rate of the survey was 19.7%. Providers with previous experience with a clinical pharmacist rated overall services as positive. 62.9% of PCPs ( = 80) provided their perception of the positive attributes (pros) of clinical pharmacy services. 53.5% of PCPs ( = 68) provided their perception of the negative attributes (cons) of clinical pharmacy services. The top three medication classes/disease states that providers indicated they would value clinical pharmacy services for were: comprehensive medication management (CMM), diabetes medication management, and anticoagulation medication management. Of the remaining areas assessed, statin and steroid management ranked the lowest.
The results from this study demonstrated that clinical pharmacy services are valued by PCPs. They also highlighted how pharmacists can best contribute to collaborative care in outpatient settings. As pharmacists, we should aim to implement the clinical pharmacy services that PCPs would value most.
存在多种临床药学服务以改善患者的健康结局。然而，其实施和执行存在众多障碍，尤其是在门诊环境中。当药剂师在门诊环境中设计和实施临床药学服务时，他们通常在服务开发之后才考虑医疗服务提供者的需求。
本研究的目的是评估初级保健提供者（PCP）对临床药学服务的看法及其临床药学支持需求。
通过电子邮件向北卡罗来纳州（NC）的PCP发放基于网络的调查问卷。调查分两个阶段完成。数据分析采用混合方法——定量和定性。描述性统计用于分析各阶段的人口统计学差异以及提供者对药物类别/疾病状态的排名。通过归纳编码进行定性数据分析，以评估提供者对临床药学服务的看法。
调查的回复率为19.7%。有临床药师工作经验的提供者对整体服务评价积极。62.9%的PCP（n = 80）提供了他们对临床药学服务积极属性（优点）的看法。53.5%的PCP（n = 68）提供了他们对临床药学服务消极属性（缺点）的看法。提供者表示他们最看重临床药学服务的前三大药物类别/疾病状态是：综合药物管理（CMM）、糖尿病药物管理和抗凝药物管理。在评估的其余领域中，他汀类药物和类固醇药物管理排名最低。
本研究结果表明临床药学服务受到PCP的重视。它们还突出了药剂师在门诊环境中如何能最好地为协作护理做出贡献。作为药剂师，我们应致力于实施PCP最看重的临床药学服务。
